Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Altia’s Board of Directors has decided on the payment of the second dividend instalment of EUR 0.21 per share for the financial year 2019

Altia Plc  Stock Exchange Release  16 November 2020 at 10:45 am EET Altia’s Board of Directors has decided on the payment of the second dividend instalment of EUR 0.21 per share for the financial year 2019 Altia’s Board of Directors has decided, on the basis of the authorisation by the Annual General Meeting 2020, on the payment of the second dividend instalment of EUR 0.21 per share. The second dividend instalment will be paid on 25 November 2020 to a shareholder registered in the shareholders’ register held by Euroclear Finland Oy on the record date 18 November 2020. On 4 June

How and why you should optimize your brand's online advent calendar this holiday season

Gone are the days of opening up a flimsy advent calendar filled with small dusty chocolates. Today’s consumers expect much more from brands - daily rewards, entertainment, freebies and dynamic content are the new normal. And retailers are capitalizing on this golden opportunity to remain at the forefront of their customers’ minds during the lucrative holiday season. Reasons your brand will benefit from an online advent calendar ✨🥇To inspire you, we’ve compiled a list of reasons and tips to make the most of an online advent calendar this holiday season! 1. Perfect for large or small

The Exercise Price for the Warrants of Series TO1 in Stayble Therapeutics AB has been set to SEK 12,30

Stayble Theraputics AB carried out during the first quarter of 2020 in conection with the listing on Nasdaq First North Growt Market, an issue of units where one unit consisted of one newly issued share and one warrant free of charge. Each warrant gives the right to subscribe one new share in the Company. The subscribtion price has been set to SEK 12,30 which is in the range of the terms and condition in the prospectus that was published in conection with the issue of units.Summarised terms for the warrants of series TO1 Subscription period for subscription of shares: November 17, 2020, –

Omnicar Holding Q3 2020 report

Please find below our Q3 2020 reportHeadlines: · Revenue totalled SEK 2.568 thousand · Q3 profit after financial income and expenses, net amounted to SEK 379 thousand · Q3 earnings per share* is SEK 0.02 for the quarter We are pleased to report our third consecutive quarter in the black. We have maintained and strengthened our financial stability and are now gearing up our business with the previously announced business line Omnicarservice. Car service at your home or at work.  During the first month of operation we had 96 customers. This number exceeded our expectations

EQT acquires majority stake in thinkproject, Europe’s leading SaaS construction intelligence platform

· EQT IX acquires a majority stake in thinkproject, Europe’s leading SaaS provider of construction intelligence solutions for the Architecture, Engineering, Construction and Owner-operated (AECO) industry · thinkproject helps improve its customers’ delivery times, reduce waste and energy consumption, while improving sustainability in one of the key carbon emitting industries globally. Its software product suite covers the full construction lifecycle and is driving digitization in one of the largest but least digitally penetrated industries · EQT aims to accelerate thinkproject’s

Bio-Works provides WorkBeads Protein A to Yumab for screening of antibody candidates now in early clinical testing against COVID-19

As a response to the COVID-19 outbreak in the spring of this year, Bio-Works offered to help by providing resins for vaccine purification research. One such project has now resulted in a neutralizing monoclonal antibody candidate against SARS-CoV-2 being produced for clinical phase 1 testing. More than 10 companies took advantage of Bio-Works’ offer of WorkBeads resins and expert advice to help speed up vaccine or treatment development against COVID-19. One of these was Yumab, a Contract Research Organization (CRO) working in a consortium together with Boehringer Ingelheim. Bio-Works

Neste among the sustainability leaders in the Dow Jones Sustainability Indices for the 14th consecutive time

Neste Corporation, Press Release, 16 November 2020 at 10 am. (EET) Neste has been selected for inclusion in the Dow Jones Sustainability Indices (DJSI) for the 14th consecutive year. The company was included in the DJSI World and DJSI Europe, once again, among the most sustainable companies in the world.  Neste’s performance received the industry’s best scores in materiality, environmental and social reporting, human capital development, and water-related risks, contributing to the company’s inclusion among the top performers. “To be once again included in the Dow Jones

COMSYS HELPS SAWMILL DOUBLE CAPACITY WITH INNOVATIVE SECOND LIFE BATTERY SOLUTION

LUND, SWEDEN; November 16, 2020  – The Swedish cleantech company Comsys AB announced today that it has successfully demonstrated the repurposing of used EV batteries for industrial peak shaving applications.Recent trials of an onsite energy storage installation built by Comsys using swapped-out EV batteries has enabled a sawmill in Germany to increase production by 100% by making it possible to run a second saw without limitation. The objective of the project was to study this second-life battery application as an alternative to installing additional capacity from the grid, which is

Strong line-up at the BioStock Life Science Summit 2020

This year’s flagship event for BioStock, the BioStock Life Science Summit, is held live in a virtual format for two days, 17 and 18 November. 27 high-profile companies, active in a number of therapeutic areas, will participate in the event, which shows the impressive breadth of Nordic life science. The program also offers the audience panel discussions with leading fund managers from e.g., C Worldwide funds, Swedbank Robur Medica, Danske Bank and Norwegian Hadean Ventures, as well as business developers from Big Pharma companies such as Amgen and Novo Nordisk.Read the full article at

Cyxone presents at BioStock Life Science Summit 17-18 November 2020

CEO Tara Heitner will present the latest updates in Cyxone on 18 November at 14.35 at the online event BioStock Life Science Summit. Information about the event together with the agenda is found on the event’s webpage . Follow the presentation live here .Contact Tara Heitner, CEOTel: +46 70 781 88 08Email: tara.heitner@cyxone.comAdelgatan 21211 22 Malmö, Sweden About Cyxone Cyxone AB (publ) (Nasdaq First North Growth Market: CYXO) develops disease modifying therapies for diseases

Almost 90 % of the convertible loan with due date December 30, 2020 will be converted into shares at a share price of SEK 3,07

SpectrumOne AB has received commitments amounting to SEK 15.1 million constituting 89 % of the total convertible debt 2019/2020 (ISIN code SE0012193290). The convertible debt was issued during the first quarter of 2019 and provided the Company with approximately SEK 17 million. Until December 15, 2020, a convertible holder can convert all or part of their convertible receivable into shares in SpectrumOne AB at a conversion price of SEK 3.07 per share (the initial price was SEK 3.25 but has been recalculated in accordance with the terms and conditions of the convertible loan). The holders

Getinge files lawsuit against insurer Moderna Försäkringar, Swedish branch of Tryg Forsikring A/S

Getinge AB and its subsidiaries Atrium Medical Corporation and Maquet Cardiovascular US Sales, LLC have filed a lawsuit against the insurer Moderna Försäkringar, Swedish branch of Tryg Forsikring A/S Danmark, to secure insurance compensation for expected costs associated with the ongoing product liability claims filed in the U.S. and Canada regarding two different types of surgical mesh products. The lawsuit will not cause any adjustment to Getinge’s previously made provision of SEK 1.8 billion related to the same claims, communicated in October 2018.Getinge’s global liability insurance

Norway Royal Salmon (NRS): Terminated discussions with NTS ASA

Reference is made to the stock exchange announcement on 13 October 2020 regarding ongoing discussions related to a possible merger between Midt-Norsk Havbruk AS and Norway Royal Salmon ASA. These discussions have now been terminated and the companies will continue their business operations as before. For more information, please contact: CEO Charles Høstlund, +47 994 18 449 CFO Ola Loe, +47 911 79 411 About Norway Royal Salmon: The Norway Royal Salmon (NRS) group owns 36 085 tonnes MAB located in Troms and Finnmark. In addition, the group has minority interest in three

The Board of Directors of Scandion Oncology has resolved on a fully guaranteed rights issue of approximately SEK 236 million

The Board of Directors in Scandion Oncology A/S ("Scandion Oncology" or the "Company") has today, 16 November 2020, pursuant to the authorization granted by the extraordinary general meeting on 13 November 2020, resolved on a fully guaranteed new share issue of 10,711,848 shares with preferential rights for the Company's existing shareholders (the "Rights Issue"). The subscription price in the Rights Issue is SEK 22 per share. The Company will receive SEK 235,660,656 prior to deduction of transaction costs related to the Rights Issue.The information in this press release is not intended for

Valmet included in the Dow Jones Sustainability Index among the world's sustainability leaders

Valmet Oyj's press release on November 16, 2020 at 9:30 a.m. EETValmet has progressed well with its Sustainability360º agenda emphasizing continuous improvement of even more sustainable business practices. As one indication of the good progress Valmet has been included in the Dow Jones Sustainability Index (DJSI) already for the seventh consecutive year. The company was listed both in the Dow Jones Sustainability World and Europe indices. The total number of companies included this year in the DJSI World for 2020-2021 is 323. The comprehensive ranking evaluates companies’ economic,

ExpreS2ion announces successful manufacturing of the cVLP COVID-19 vaccine and further positive updates

Hørsholm, Denmark, November 16, 2020 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that the capsid virus like particle (cVLP) based COVID-19 vaccine, which is licensed to Bavarian Nordic, has been successfully manufactured with a full batch release to follow after final quality analysis. The project remains on track for presenting initial clinical Phase I/IIa results in Q1 2021, depending on the speed of the clinical trial application (CTA) approval procedure. Furthermore, the cVLP technology and manufacturing processes used are perfectly

Swedbank added to Dow Jones Sustainability Index 2020

Swedbank has qualified for the Dow Jones Sustainability Index 2020, one of the world’s most influential sustainability indices. Each year the index ranks the world’s most sustainable companies, and being selected is proof of Swedbank’s consistent and effective sustainability work in terms of the environment, economy and social criteria.The ranking is based on questions on corporate governance, risk management, brand building, human rights, climate change and labour practices. “With our sights set on an economically sound and sustainable society, we are very happy and proud to be selected

BillerudKorsnäs leader in Dow Jones Sustainability Index – for the third year in a row

An integrated sustainability work and an ambition to constantly meet customers' sustainability requirements are reasons why BillerudKorsnäs maintains its leading position for the third year in a row, according to the Dow Jones Sustainability Index – a globally recognized sustainability ranking for investors. The results from this year's ranking show that BillerudKorsnäs is one of the ten percent most sustainable companies and the company with the highest score in the Containers & Packaging category.S&P Corporate Sustainability Assessment (CSA) is a comprehensive annual evaluation of

An air purifier reduces the risk of corona

It is possible to significantly reduce the risk of Corona and viruses with the help of an air purifier. But it is important to choose the right one, if you are to have any real effect.To understand, it is good to start from scratch to highlight the difference between ventilation and air purification. The ventilation - regardless of whether it is mechanical or based on natural draft, aims to take in fresh air so we get enough oxygen and do not get tired. But for this air to be clean, an air purifier is required. What has been at the forefront today when it comes to air purification is

Building of Finland’s first quantum computer begins – VTT partners with quantum startup IQM

Press release 16 November, 2020VTT and IQM have entered into an agreement to establish a co-innovation partnership and begin building Finland’s first quantum computer. The cooperation will bring together top expertise in quantum technologies and enable a leap in Finland’s quantum capabilities. The government of Finland has granted the project EUR 20.7 million funding.The computer will be built in Espoo, Finland at VTT’s and Aalto University’s joint national research infrastructure Micronova, where the clean room environment used to manufacture the quantum components is located. Work will

Vicore Pharma recruits the first patient in the phase II Proof-of-Concept study in idiopathic pulmonary fibrosis

Gothenburg, November 16, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces that the first patient in the phase II idiopathic pulmonary fibrosis (IPF) study has been recruited in India.Dr. Himanshu Pop Hale, Ace Hospital Pune, India, has recruited the first patient in the IPF phase II Proof-of-Concept study with C21 (VP01 project). “We are pleased to announce that we can now start our IPF trial despite the ongoing COVID-19 pandemic.” says Anne Katrine Cohrt, Senior Director Clinical

There are no items matching the current filter
There are no more items matching the current filter
Back to top